Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs.

The tumour blood flow inhibitor 5,6-dimethylxanthenone-4-acetic acid (DMXAA) causes dramatic haemorrhagic necrosis in murine tumours, but activity is seen only at doses close to the toxic limit. This study investigates two approaches for increasing the therapeutic ratio of DMXAA. The first approach...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Lash, C. J., Li, A. E., Rutland, M., Baguley, B. C., Zwi, L. J., Wilson, W. R.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group|1 1998
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2063102/
https://ncbi.nlm.nih.gov/pubmed/9716024
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk